NEAT1 and Alzheimer disease: Additionally, miR-27a-3p and NEAT1 showed consistent expression trends in AD patients, with decreased levels of miR-27a-3p and increased NEAT1 in serum correlating with disease severity and Aβ deposition, suggesting their involvement in AD progression [158].